DF/HCC Kidney Cancer SPORE Administrative Core
DF/HCC 肾癌 SPORE 管理核心
基本信息
- 批准号:10206019
- 负责人:
- 金额:$ 28.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-18 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdministratorAdvocateApplications GrantsAwardBiological MarkersCancer CenterCancer PatientCancer SurvivorCaringChargeClinical Cancer CenterClinical SciencesClinical TrialsCollaborationsCommunicationCommunity OutreachComplementDatabasesDevelopmentDiagnosisDiseaseEducational ActivitiesEnsureEvaluationEventFosteringFundingFutureGoalsGrantGuidelinesIndividualInstitutionIntellectual PropertyInternationalLeadershipLicensingMinorityMinority ParticipationMinority RecruitmentMonitorNamesNewsletterPatient ParticipationPatientsProcessProgress ReportsProperty RightsPublicationsRenal carcinomaReportingResearchResearch PersonnelResearch Project GrantsResourcesRisk FactorsScientific Advances and AccomplishmentsSecureStructureTechnologyTexasUnited States National Institutes of HealthUniversitiesWorkanticancer researchauthoritycancer therapycareercareer developmentcostfollow-upinterestmeetingsmemberminority communitiesminority investigatoroperationprogramssuccesssymposiumtoolweb site
项目摘要
Summary
The purpose of the Administration, Evaluation and Planning (Administrative) Core is to assure the
coordination of the Dana Farber/Harvard Cancer Center (DF/HCC) Kidney Cancer SPORE components and
to continue to provide oversight and leadership for the scientific, administrative and fiscal aspects of the
SPORE. The Administrative Core allows for the provision of stimulating intellectual activities, organization of
venues for planning future research through seminars and retreats, and the oversight of research and
spending. Drs. McDermott and Kaelin, the SPORE Directors, are committed to the success of the SPORE
and will personally monitor the progress of the Projects and Cores, oversee the Career Development and
Developmental Research Programs, and oversee all other proposed activities. As both SPORE Directors
and Leaders of the Kidney Cancer Program within the Dana-Farber/Harvard Center (DF/HCC), Drs.
McDermott and Kaelin have the authority and resources to ensure the success of this SPORE. The
Administrative Core of the DF/HCC Kidney Cancer SPORE will accomplish the goals of the SPORE by
following six specific aims: 1) Monitor research progress and plan for the future, 2) foster collaborative
research within and between SPOREs, 3) Integrate the DF/HCC Kidney Cancer SPORE into the structure
of DF/HCC, 4) Provide necessary resources and fiscal oversight, 5) promote patient participation,
particularly minorities, in Kidney Cancer research and treatment 6) Promote rapid dissemination of
significant research findings and free and open communication and resource exchange between the
DF/HCC SPORE and other institutions. As they have since early 2014, Drs. McDermott and Kaelin will
provide the tools to foster collaborations between the institutions inside and outside of the SPORE, to
leverage the considerable power of the SPORE in order to promote kidney cancer research.
概括
政府,评估和计划(行政)核心的目的是确保
Dana Farber/哈佛癌中心(DF/HCC)肾癌孢子成分和
继续为科学,行政和财政方面提供监督和领导
孢子。行政核心允许提供刺激的智力活动,组织
通过研讨会和务虚会计划未来研究的场所,以及对研究的监督
开支。博士。孢子导演麦克德莫特(McDermott)和凯林(Kaelin)致力于孢子的成功
并将亲自监视项目和核心的进度,监督职业发展和
发展研究计划,并监督所有其他建议的活动。作为两个孢子导演
Drs。
麦克德莫特(McDermott)和凯琳(Kaelin)拥有确保孢子成功的权力和资源。这
DF/HCC肾癌孢子的行政核心将实现孢子的目标
以下六个具体目标:1)监控未来的研究进度和计划,2)促进协作
孢子内和之间的研究,3)将DF/HCC肾癌孢子整合到结构中
DF/HCC,4)提供必要的资源和财政监督,5)促进患者参与,
特别是少数民族,在肾脏癌研究和治疗中6)
重大的研究发现以及自由和开放的沟通和资源交流
DF/HCC孢子和其他机构。自2014年初以来,Drs。麦克德莫特和凯琳将
提供工具来促进孢子内外机构之间的协作,以
利用孢子的相当大能力来促进肾脏癌研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David McDermott其他文献
David McDermott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David McDermott', 18)}}的其他基金
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
肾损伤分子 1 (KIM-1) 作为肾细胞癌生物标志物的临床特征
- 批准号:
10365631 - 财政年份:2021
- 资助金额:
$ 28.41万 - 项目类别:
Clinical characterization of Kidney Injury Molecule-1 (KIM-1) as a Biomarker in Renal Cell Carcinoma
肾损伤分子 1 (KIM-1) 作为肾细胞癌生物标志物的临床特征
- 批准号:
10541150 - 财政年份:2021
- 资助金额:
$ 28.41万 - 项目类别:
Project 3: HHLA2 as a THerapeutic Target in RCC
项目 3:HHLA2 作为 RCC 的治疗靶点
- 批准号:
10206027 - 财政年份:2003
- 资助金额:
$ 28.41万 - 项目类别:
DF/HCC Kidney Cancer SPORE Administrative Core
DF/HCC 肾癌 SPORE 管理核心
- 批准号:
10705111 - 财政年份:2003
- 资助金额:
$ 28.41万 - 项目类别:
Project 3: HHLA2 as a THerapeutic Target in RCC
项目 3:HHLA2 作为 RCC 的治疗靶点
- 批准号:
10705141 - 财政年份:2003
- 资助金额:
$ 28.41万 - 项目类别:
相似海外基金
Staffing and Health Outcomes in Nursing Homes for Residents with and without Dementia
疗养院中患有和未患有痴呆症的居民的人员配备和健康状况
- 批准号:
10621699 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Staffing and Health Outcomes in Nursing Homes for Residents with and without Dementia
疗养院中患有和未患有痴呆症的居民的人员配备和健康状况
- 批准号:
10171551 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别:
Staffing and Health Outcomes in Nursing Homes for Residents with and without Dementia
疗养院中患有和未患有痴呆症的居民的人员配备和健康状况
- 批准号:
10368160 - 财政年份:2020
- 资助金额:
$ 28.41万 - 项目类别: